EXOPHARM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0275 AUD | +10.00% |
|
-.--% | -.--% |
| Feb. 26 | Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | Exopharm to Cut CEO Role Amid Cost Reductions | MT |
Performance
| 1 day | +10.00% | ||
| 1 year | -26.67% | ||
| 3 years | -98.69% | ||
| 5 years | -97.41% |
Volumes
marketsDaily volume
29 049
Estimated daily volume
29 049
Record volume 1
8 321 108
Record volume 2
5 444 500
Record volume 3
4 294 944
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
4 813 143
Capitalization (USD)
3 136 292
Net sales (AUD)
3 393 141
Net sales (USD)
2 211 005
Free-Float
24.71 %
Free-Float capitalization (AUD)
2 973 825
Free-Float capitalization (USD)
1 937 774
Highs and lows
1 year
0.01
0.05
3 years
0.012.10
5 years
0.012.50
10 years
0.012.50
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.02
Moving average 50 days
0.02
Moving average 100 days
0.01
Price spread / (MMA5)
-62.18%
Price spread / (MMA20)
-13.09%
Price spread / (MMA50)
-12.00%
Price spread / (MMA100)
-64.73%
RSI 9 days
65.56
RSI 14 days
61.18
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.00% | -.--% | -.--% | -26.67% | 3.14M | ||
| -2.85% | +3.00% | +1.12% | +22.05% | 43.84B | ||
| -2.45% | +4.10% | +6.77% | -21.29% | 41.68B | ||
| -1.72% | +0.71% | +45.26% | -7.72% | 41.25B | ||
| -1.17% | +3.74% | -11.96% | +6.55% | 27.04B | ||
| -3.02% | +2.83% | +6.01% | +47.66% | 25.53B | ||
| -0.06% | -1.00% | -24.92% | -28.91% | 18.18B | ||
| -4.85% | +0.11% | -3.63% | +21.43% | 12.29B | ||
| -1.96% | +4.13% | +27.16% | +87.15% | 12.29B | ||
| -0.44% | -0.41% | +7.30% | +4.26% | 11.15B | ||
| -1.35% | +0.72% | -18.79% | -20.41% | 9.98B | ||
| -1.06% | +4.08% | -8.25% | -9.72% | 9.19B | ||
| -1.30% | +1.72% | +22.92% | -16.29% | 6.64B | ||
| -1.44% | +2.52% | -17.30% | +16.61% | 6.19B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +0.78% | +0.47% | -3.57% | -43.59% | 5.88B | ||
| Average | -0.80% | +2.88% | +1.88% | +2.07% | ||
| Weighted average by Cap. | -1.91% | +3.35% | +6.29% | +5.37% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2023 | -81.67% | ||
| 2022 | -88.46% | ||
| 2021 | -8.77% | ||
| 2020 | +119.23% | ||
| 2019 | -52.73% | ||
| 2018 | +5.77% |
- Stock Market
- Equities
- EX1 Stock
- Quotes Exopharm Limited
